Oncolytics Biotech Inc. (ONCY)

[onco_investor]

Oncolytics at JMP Securities Healthcare Conference Sept28th

http://www.newswire.ca/en/releases/archive/September2011/22/c5620.html

Media Advisory - Oncolytics Biotech® Inc. to Present at the JMP Securities Healthcare Conference
CALGARY, Sept. 22, 2011 /CNW/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the JMP Securities Healthcare Conference on Wednesday, September 28th, 2011 at 12:30 p.m. ET. The conference will take place on September 27th and 28th at the St. Regis New York Hotel in New York, NY.

A live audio link to the webcast presentation will be available at: http://wsw.com/webcast/jmp14/oncy/ or on the company's website at www.oncolyticsbiotech.com. It is recommended that listeners log on 10 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible approximately one hour following the presentation on the Oncolytics website.

About Oncolytics Biotech Inc.
Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN®, its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.